Topics: RheumatologyMyositisIVIG
Would you consider starting IVIG as initial steroid-sparing agent instead of azathioprine/methotrexate in a patient with inflammatory myopathy, high Jo-1, weakness with severe dysphagia and without skin involvement or ILD?  


Answer from: at Academic Institution
Comments
at Community Healthcare System
Thanks for the input.
Sign in or Register to read more